EUVIMEDEUVIMED entdecken
Open Access

Accounting for local incidence when estimating rotavirus vaccine efficacy among countries: a pooled analysis of monovalent rotavirus vaccine trials

Avnika B Amin iD, Lance A Waller iD, Jacqueline E Tate iD, Timothy L Lash iD, Benjamin A Lopman iD

American Journal of Epidemiology · 2025

DOI: 10.1093/aje/kwae467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Avnika B Amin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States. Hauptthemen laut MEDLINE: Rotavirus Vaccines, Rotavirus Infections, Gastroenteritis, Vaccine Efficacy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rotavirus vaccine appears to perform suboptimally in countries with higher rotavirus burden. We hypothesized that differences in the magnitude of rotavirus exposures may bias vaccine efficacy (VE) estimates, so true differences in country-specific rotavirus VE would be exaggerated without accommodating differences in exposure. We estimated VE against any-severity and severe rotavirus gastroenteritis (RVGE) using Poisson regression models fit to pooled individual-level data from phase II and III monovalent rotavirus vaccine trials conducted between 2000 and 2012. The standard approach model included terms for vaccination, country, and a vaccination-country interaction. Other models used proxies for exposure magnitude like severe RVGE rate or age at severe RVGE instead of country. Country-specific proxies were calculated from placebo group data or extracted from an external meta-analysis. Analyses included 83 592 infants from 23 countries in the Americas, Europe, Africa, and Asia. Using the standard approach, VE against severe RVGE substantially varied (10%–100%). Using the severe RVGE rate proxy brought VE from all but 2 countries between 80% and 86%. Heterogeneity for VE against any-severity RVGE was similarly attenuated. Adjusting for exposure proxies reduced heterogeneity in country-specific rotavirus VE estimates. This phenomenon may extend to other vaccines against partially immunizing pathogens with global disparities in burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rotavirus VaccinesRotavirus InfectionsGastroenteritisVaccine EfficacyHumansInfantIncidenceAfricaAsiaEuropeAmericas

Stichwörter der Autor:innen

biasclinical trialsforce of infectioninfectious exposuresrotavirusvaccine efficacy

Substanzen

Rotavirus Vaccines

Autor:innen und Institutionen

  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
  • Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
  • Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

ORCID-Profile: Avnika B Amin, Lance A Waller, Jacqueline E Tate, Timothy L Lash, Benjamin A Lopman

Förderung

  • Intramural CDC HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Amin, A. B., Waller, L. A., Tate, J. E., Lash, T. L., & Lopman, B. A. (2025). Accounting for local incidence when estimating rotavirus vaccine efficacy among countries: a pooled analysis of monovalent rotavirus vaccine trials. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwae467

Vancouver

Amin AB, Waller LA, Tate JE, Lash TL, Lopman BA. Accounting for local incidence when estimating rotavirus vaccine efficacy among countries: a pooled analysis of monovalent rotavirus vaccine trials. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwae467

BibTeX
@article{Amin2025,
  author = {Amin, Avnika B and Waller, Lance A and Tate, Jacqueline E and Lash, Timothy L and Lopman, Benjamin A},
  title = {Accounting for local incidence when estimating rotavirus vaccine efficacy among countries: a pooled analysis of monovalent rotavirus vaccine trials},
  journal = {American Journal of Epidemiology},
  year = {2025},
  doi = {10.1093/aje/kwae467}
}
Kostenlos starten →